Administrative Core
行政核心
基本信息
- 批准号:10044048
- 负责人:
- 金额:$ 10.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alaska NativeCaliberCancer ScienceCollaborationsColorectal CancerCommunicationCommunitiesDevelopmentEducationEnsureEvaluationFosteringFoundationsFred Hutchinson Cancer Research CenterFundingGoalsGovernmentGrantHealth systemIncubatedInfrastructureInstitutionLeadLeadershipLettersMonitorNational Cancer InstitutePathologyPersonsPreparationResearchResearch PersonnelResource SharingResourcesUnderrepresented MinorityUpdateVideoconferencesWorkcancer health disparitycareercareer developmentcommunity based participatory researchhuman subject protectioninnovationmeetingsminority scientistorganizational structureprogramsracial and ethnic disparitiessuccesstranslational research programtribal health
项目摘要
Project Summary/Abstract of the Administrative Core
The Administrative Core (AC) will serve to support and integrate the activities conducted by the Translational
Research Program in Colorectal Cancer Disparities (TRPCD) including the Full Projects, the Biospecimen and
Pathology Core (BPC), and the Developmental Research Program (DRP). Additionally, as part of this Core, we
will develop and initiate a Career Enhancement Program (CEP) to identify and support promising junior
investigators, and those new to the field of cancer disparities. The AC will provide formal coordination of efforts
involving the following entities:
1. All TRPCD investigators
2. The Executive Committee (EC) and Advisory Boards, including the External Advisory Board (EAB), the
Internal Advisory Board (IAB), and the Community Advisory Board (CAB)
3. Review Panels evaluating applications to the DRP
4. Representatives of the National Cancer Institute
5. New external partnerships built through this program including, but not limited to, those involving existing
SPOREs and other funded disparities P20 programs
This Core has the following specific aims:
Aim 1. To provide the organizational structure, leadership, and administrative support requisite for successful
execution of key TRPCD objectives.
Aim 2. To coordinate TRPCD activities with various projects, programs, and shared resources at participating
institutions such that integration of these existing institutional resources will successfully support the
TRCPD and lead to the development of a full P50 SPORE application.
Aim 3. To do the following planning and evaluation activities: organize regular EC/EAB/IAB/CAB meetings,
provide rigorous fiscal oversight and management while ensuring compliance with all relevant
institutional requirements, provide career development opportunities to investigators (including
development of a SPORE-caliber CEP), maintain open lines of communication with NCI, initiate and
sustain collaborations with key external partners, and monitor and update a transition plan to a full P50
SPORE grant.
项目摘要/行政核心摘要
行政核心 (AC) 将用于支持和整合转化中心开展的活动
结直肠癌差异研究计划 (TRPCD),包括完整项目、生物样本和
病理学核心 (BPC) 和发展研究计划 (DRP)。此外,作为该核心的一部分,我们
将制定并启动职业提升计划(CEP),以识别和支持有前途的青年
研究人员以及癌症差异领域的新人。审计委员会将提供正式的工作协调
涉及以下实体:
1. 所有 TRPCD 调查员
2. 执行委员会(EC)和顾问委员会,包括外部顾问委员会(EAB)、
内部顾问委员会 (IAB) 和社区顾问委员会 (CAB)
3. 审查小组评估 DRP 申请
4.国家癌症研究所代表
5. 通过该计划建立的新的外部伙伴关系,包括但不限于现有的伙伴关系
SPORE 和其他资助的差异 P20 计划
该核心有以下具体目标:
目标 1. 提供成功所需的组织结构、领导力和行政支持
执行 TRPCD 关键目标。
目标 2. 协调 TRPCD 活动与参与的各种项目、计划和共享资源
机构,整合这些现有机构资源将成功支持
TRCPD 并导致了完整 P50 SPORE 应用程序的开发。
目标 3. 开展以下规划和评估活动:定期组织 EC/EAB/IAB/CAB 会议,
提供严格的财政监督和管理,同时确保遵守所有相关规定
机构要求,为研究者提供职业发展机会(包括
开发 SPORE 级别的 CEP),与 NCI 保持开放的沟通渠道,启动并
维持与主要外部合作伙伴的合作,并监控和更新向完整 P50 的过渡计划
孢子补助金。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ULRIKE PETERS其他文献
ULRIKE PETERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ULRIKE PETERS', 18)}}的其他基金
Project 2: Racial/ethnic differences, impact on tumor microenvironment and mortality
项目2:种族/民族差异、对肿瘤微环境和死亡率的影响
- 批准号:
10044050 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation
通过扩大种族/族裔少数群体代表性,促进结直肠癌遗传风险预测的公平性
- 批准号:
10433925 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation
通过扩大种族/族裔少数群体代表性,促进结直肠癌遗传风险预测的公平性
- 批准号:
10180920 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Project 2: Racial/ethnic differences, impact on tumor microenvironment and mortality
项目2:种族/民族差异、对肿瘤微环境和死亡率的影响
- 批准号:
10466939 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation
通过扩大种族/族裔少数群体代表性,促进结直肠癌遗传风险预测的公平性
- 批准号:
10688163 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
相似海外基金
CALIBER: Conductive Additives to reduce Lithium Ion Battery Electrode Resistance
CALIBER:降低锂离子电池电极电阻的导电添加剂
- 批准号:
10004505 - 财政年份:2021
- 资助金额:
$ 10.28万 - 项目类别:
BEIS-Funded Programmes
Functional evaluation of bioabsorbable small-caliber vascular graft in a diabetic rat model to achieve a practical use
生物可吸收小口径血管移植物在糖尿病大鼠模型中的功能评价以实现实用化
- 批准号:
21K08812 - 财政年份:2021
- 资助金额:
$ 10.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Enhanced degradability of bioabsorbable small-caliber artificial vessels to promote autologous vascular regeneration
增强生物可吸收小口径人工血管的降解性促进自体血管再生
- 批准号:
21K20938 - 财政年份:2021
- 资助金额:
$ 10.28万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
- 批准号:
518445-2018 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Postgraduate Scholarships - Doctoral
Morphological and Biochemical Profiling of the Degeneration of Small Caliber Axons Using a Murine Model for Myelin-related Diseases
使用髓磷脂相关疾病的小鼠模型对小口径轴突变性进行形态学和生化分析
- 批准号:
20KK0188 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Elucidation of the mechanism of small caliber axons' myelination in the central nervous system and its application
中枢神经系统小口径轴突髓鞘化机制的阐明及其应用
- 批准号:
20K07756 - 财政年份:2020
- 资助金额:
$ 10.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vitro endothelialization of small caliber vascular prostheses made of bacterial nanocellulose depending on coating with albumin, fibronectin or heparin
由细菌纳米纤维素制成的小口径血管假体的体外内皮化取决于白蛋白、纤连蛋白或肝素的涂层
- 批准号:
421965288 - 财政年份:2019
- 资助金额:
$ 10.28万 - 项目类别:
Research Grants
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
- 批准号:
518445-2018 - 财政年份:2019
- 资助金额:
$ 10.28万 - 项目类别:
Postgraduate Scholarships - Doctoral
Anti-atherosclerotic action of platelet-derived endothelial cell growth factor to improve patency of small-caliber artificial blood vessels
血小板源性内皮细胞生长因子的抗动脉粥样硬化作用可改善小口径人造血管的通畅性
- 批准号:
18K08753 - 财政年份:2018
- 资助金额:
$ 10.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering a biomimetic small caliber vascular prosthesis: fabrication of an anti-thrombogenic endothelium from the stromal vascular fraction of adipose tissue
设计仿生小口径血管假体:从脂肪组织的基质血管部分制造抗血栓内皮
- 批准号:
518445-2018 - 财政年份:2018
- 资助金额:
$ 10.28万 - 项目类别:
Postgraduate Scholarships - Doctoral